Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kids Neuroscience Centre, |
RCV001726531 | SCV001571514 | uncertain significance | Lynch syndrome 1 | criteria provided, single submitter | clinical testing | Out-of-frame exon 6 skipping (r.3439_3556del) causes a frameshift encoding 8 missense amino acids and a premature termination codon (p.(Ala1147Valfs*9)). These transcripts are predicted to be targeted by nonsens e mediated decay (NMD). Any mis-spliced transcipts that escape NMD encode MSH6 protein lacking 215 amino acids from the C -terminus, including 180 amino acids from the MutS domain. Intron 6 retention (r.3556_3557ins[3556+1_3557-1]) causes a frameshift encoding 16 missense amino acids and a premature termination codon (p.(Glu1187Aspfs*17)). These transcripts are predicted to be targeted by NMD. Any mis spliced transcipts that escape NMD encode MSH6 protein lacking 174 amino acids from the C -terminus, including 139 amino acids from the MutS domain. | |
Ambry Genetics | RCV002456593 | SCV002617795 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-02-14 | criteria provided, single submitter | clinical testing | The c.3556+5_3556+8delGTTTins13 intronic variant, located in intron 6 of the MSH6 gene, results from a deletion of 4 nucleotides and the insertion of 13 nucleotides at nucleotide positions c.3556+5 to c.3556+8. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the native splice donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |